.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

TobraDex ST: A Reliable Treatment for Blepharitis and Inflammation With Increased Ocular Bio-Availability

This program is sponsored by Santen.

EP. 1: Case 1: A 41-Year-Old Female With Eye Redness

January 27th 2022

This program is sponsored by Santen.

EP. 2: Case 2: A 59-Year-Old Male With Lid Erythema and toothpaste like secretions

January 27th 2022

This program is sponsored by Santen.

EP. 3: Case 3: A 39-Year-Old Female With Conjunctival Redness and Swelling

January 27th 2022

This program is sponsored by Santen.

EVC-21-WB-165-00

Latest News

Poll: Do you believe biosimilars have the same efficacy as branded medications?

Opus Genetics receives FDA Clearance of IND application for OPGx-001 for treatment of retinal disease LCA5

Prevent Blindness marking second Geographic Atrophy Awareness Week on Dec. 5-11

View More Latest News